Cynata Therapeutics Ltd has released a press release.
September 2017 Quarterly Report
Filed with ASX ·
6ix hasn’t read this filing yet.
Cynata Therapeutics Limited on 6ix
Story so far
Earlier from Cynata Therapeutics
- Notice of Annual General Meeting/Proxy Form
- Cynata to Increase Exposure in Japan
- US Patent Granted for Cynata Cymerus Technology
- Health Canada Meeting Advances CYP Global Development Plans
- Positive Data from CYP MSCs in 2nd Preclinical Asthma Study
Later from Cynata Therapeutics
- Enrolment Completed in 1st Cohort of Cynata Clinical Trial
- United States Patent Allowance for Core Cynata Technology
- Final Preclinical Asthma Study Confirms Efficacy
- Encouraging Early Data-Cynata Clinical Trial Proceeds
- Cyanta & Celularity Inc Execute MOU
Follow Cynata Therapeutics into a list and get an email when it puts out news.
Follow Cynata Therapeutics